Salesforce, Inc. (CRM) › Analysis

Salesforce, Inc. (CRM) analysis, February 11, 2026

Published February 11, 2026 · CRM chart, levels and live analysis

Key Updates

Salesforce has declined 4.77% to $185.00 since the February 9 report, breaking below the $190 support level that had provided temporary stabilization. The stock now trades 30.16% below its year-to-date starting point and has lost 28.68% over the past month, establishing a new multi-year low. This latest decline follows the announcement that Salesforce will discontinue Enterprise Heroku subscriptions and scale back feature development, signaling a strategic pivot away from legacy PaaS offerings toward enterprise AI solutions. Despite this negative development, the $5.6 billion U.S. Army contract announced in late January provides a substantial long-term revenue opportunity, though its impact will materialize gradually as orders are placed.

Current Trend

The downtrend remains firmly intact with Salesforce declining 30.16% year-to-date and 20.49% over six months. The stock has breached multiple support levels sequentially—$200, $195, and now $190—with each breakdown accelerating selling pressure. The current price of $185.00 represents a new cycle low and reflects sustained distribution. Short-term momentum indicators show no signs of stabilization, with the 5-day decline of 7.24% demonstrating continued weakness. The stock has underperformed the broader market significantly, with the S&P 500's modest year-to-date decline of approximately 0.9% (as referenced in the January 21 Forbes article) contrasting sharply with CRM's 30%+ loss. No meaningful resistance levels have been established on the downside, suggesting further technical deterioration is possible without a fundamental catalyst.

Investment Thesis

The investment thesis centers on Salesforce's transition from traditional SaaS provider to enterprise AI platform leader, balanced against competitive pressures and AI-driven disruption risks. The company maintains solid fundamentals with 8.4% revenue growth to $40 billion, a 22% operating margin exceeding the S&P 500 average of 18.8%, and a conservative debt-to-equity ratio of 4.9%. The $5.6 billion U.S. Army IDIQ contract over 10 years provides visibility into government revenue streams and validates Salesforce's national security capabilities. However, the Heroku discontinuation signals strategic retrenchment from legacy products facing competitive pressure from major cloud providers (AWS, Azure, Google Cloud). The core thesis requires successful monetization of AI capabilities through products like Agent Builder to offset concerns that advanced AI technology may reduce demand for high-margin SaaS services. At a P/S ratio of 5.7x versus the S&P 500's 3.3x, the stock trades at a premium despite trading below its five-year historical average of 8x, suggesting the market is pricing in execution risk on the AI transition.

Thesis Status

The thesis faces increased pressure as new developments reveal both strategic challenges and opportunities. The Heroku scale-back confirms concerns about competitive encroachment from hyperscale cloud providers and potential product overlap within Salesforce's own portfolio, validating bear arguments about margin compression and market share erosion. This strategic retreat contradicts the growth narrative and suggests management is prioritizing resource allocation toward higher-return AI investments. Conversely, the $5.6 billion Army contract demonstrates Salesforce's ability to secure large-scale, long-duration government engagements, supporting the thesis that enterprise relationships provide defensive moats. The thesis remains viable but requires successful execution on AI monetization to offset legacy product headwinds. The 30% year-to-date decline has created valuation support, with analyst price targets averaging $329 (as of mid-January when the stock traded near $240), implying substantial upside if execution improves. However, the gap between current price ($185) and analyst targets has widened, suggesting either analysts have not fully incorporated recent negative developments or the market is overly pessimistic.

Key Drivers

Strategic product rationalization is reshaping Salesforce's portfolio, with the company discontinuing Enterprise Heroku subscriptions and redirecting engineering resources toward enterprise-grade AI solutions. This decision reflects intensifying competition from major cloud providers offering equivalent PaaS capabilities and potential cannibalization from newer Salesforce products like Agent Builder. The $212 million Heroku acquisition from 2011 has become strategically redundant, forcing management to acknowledge competitive realities.

Government contracting expansion provides a significant long-term growth vector, with the $5.6 billion U.S. Army contract representing a ceiling for potential orders over 10 years. The agreement leverages Salesforce's decade-long relationship with U.S. Armed Forces and will deploy Missionforce National Security capabilities across personnel management, recruiting, training, and operational efficiency functions. Financial impact will materialize as orders are placed, with detailed contribution metrics expected during Q4 earnings.

AI disruption concerns continue to weigh on valuation, with sector-wide fears that advanced AI technology may reduce demand for high-margin SaaS services. This structural concern has driven increased bearish sentiment and put option purchases, contributing to the $44 billion market capitalization loss over an 8-day period in late January. The market is questioning whether AI will enhance or cannibalize traditional SaaS revenue streams.

Insider activity has added to negative sentiment, with Director Neelie Kroes divesting 3,893 shares worth approximately $929,259, though this represents routine portfolio management rather than a definitive bearish signal.

Technical Analysis

Salesforce has entered a sustained downtrend with no technical support levels holding. The stock broke $200 in early February, then $195, $190, and now trades at $185, establishing a pattern of lower lows. The 1-month decline of 28.68% represents capitulation-level selling, while the 30.16% year-to-date loss has eliminated all 2026 gains and extended 2025's 20% decline. Volume patterns suggest institutional distribution rather than retail panic, with the $44 billion market cap loss in late January occurring over 8 trading days rather than a single event. The current price of $185 offers no clear support level, with the next potential floor at $175 or lower. Resistance has formed at $195, then $200, creating a downward staircase pattern. The stock's historical volatility during market stress—including a 58.6% decline during the 2022 inflation shock—suggests further downside is possible if macro conditions deteriorate. No bullish technical patterns are evident, and momentum indicators remain negative across all timeframes from 1-day to year-to-date.

Bull Case

Bear Case

Get a message when the CRM picture changes — the agent team watches the levels and the news for you.Create a free account

More CRM analyses